Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RubaXX Cannabis CBD Gel is a topical cosmetic gel developed by PharmaSGP. It is formulated with approximately 600 mg to 900 mg of pure cannabidiol (CBD) isolated from *Cannabis sativa L.*, combined with cooling menthol and mint oil. The gel is designed to support and soothe strained, tense, or overworked muscles (such as in the back, shoulders, or legs) by providing a cooling, moisturizing, and relaxing sensation on the skin. It is manufactured under strict German quality standards, contains no THC, and is dermatologically tested for daily use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RubaXX Cannabis CBD Gel.